MedPath
HSA Approval

KLERIMED 250 TABLET 250 mg

SIN11969P

KLERIMED 250 TABLET 250 mg

KLERIMED 250 TABLET 250 mg

May 30, 2002

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01FA09

clarithromycin

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD (FACTORY AZ)

MEDOCHEMIE (FAR EAST) LTD. (ORAL FACILITY)

Active Ingredients

CLARITHROMYCIN 257 MG EQV ANHYDROUS CLARITHROMYCIN

250 mg

Clarithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KLERIMED 250 TABLET 250 mg - HSA Approval | MedPath